Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Axillary Dissection, Sentinel Biopsy, and Tumor Lesion Localization in Breast Cancer Patients Using the New Magnetic "Sentimag" Detection System

NCT05161507 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.

NCT NCT05161507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05161507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Axillary Dissection, Sentinel Biopsy, and Tumor Lesion Localization in Breast Cancer Patients Using the New Magnetic "Sentimag" Detection System
Lead sponsor
University Hospital Ostrava
Phase
Observational
Overall status
Completed
Start date
May 4, 2020
Completion date
December 31, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, breast carcinoma metastatic in lymph node